Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during the intervention, and following the intervention.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: f
View:
• Assigned female at birth
• Age 18 to 45
• Naturally cycling
• Regularly occurring menstrual cycle
• Must identify as having PMS or PMDD
• Reliable ability to complete online study surveys
• Assigned female at birth.
• Age 40 to 55
• Must have newly variable menstrual cycles or report identifying as perimenopausal
• Reliable ability to complete online study surveys
Locations
United States
Texas
Texas Christian University
RECRUITING
Fort Worth
Contact Information
Primary
Sarah E Hill, PhD
s.e.hill@tcu.edu
817-257-6424
Backup
Savannah A Hastings, M.S.
s.a.hastings@tcu.edu
817-257-4989
Time Frame
Start Date: 2026-06
Estimated Completion Date: 2027-03
Participants
Target number of participants: 20
Treatments
Experimental: tAN treatment
For perimenopausal women: tAN administration 2 hours daily. For PMS/PMDD women: tAN administration 2 hours daily during the luteal phase.
Related Therapeutic Areas
Sponsors
Collaborators: Spark Biomedical, Inc.
Leads: Texas Christian University